We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$640M
AUM Growth
+$42M
Cap. Flow
+$22.9M
Cap. Flow %
3.57%
Top 10 Hldgs %
39.6%
Holding
108
New
27
Increased
17
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
PRAX icon
Praxis Precision Medicines
PRAX
+$8.95M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$7.93M
3
SHLT
SHL Telemedicine Ltd American Depositary Shares
SHLT
+$7.92M
4
NVMI
Nova
NVMI
+$7.16M
5
TSEM icon
Tower Semiconductor
TSEM
+$6.92M

Top Sells

Rank Stock Value
1
NTR icon
Nutrien
NTR
+$10.7M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$8.87M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$8.02M
4
LLY icon
Eli Lilly
LLY
+$6.71M
5
MSFT icon
Microsoft
MSFT
+$6.37M

Sector Composition

Rank Sector Weight
1 Healthcare 57.28%
2 Technology 9.65%
3 Consumer Discretionary 2.53%
4 Utilities 0.59%
5 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEVA icon
1
CALL
Teva Pharmaceuticals
TEVA
$40.8B
$61.3M 9.58%
8,144,700
+6,107,700
+300% +$49.5M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$453B
$46.5M 7.27%
+126,000
New +$42.4M
SNY icon
3
Sanofi
SNY
$103B
$28.5M 4.46%
529,515
– –
AZN icon
4
AstraZeneca
AZN
$263B
$20.4M 3.19%
142,530
– –
JNJ icon
5
Johnson & Johnson
JNJ
$618B
$19.8M 3.1%
119,831
– –
NICE icon
6
Nice
NICE
$5.79B
$18.1M 2.82%
87,482
-28,000
-24% -$5.78M
AMZN icon
7
Amazon
AMZN
$2.92T
$16.2M 2.53%
124,300
+38,620
+45% +$4.41M
SNDX icon
8
Syndax Pharmaceuticals
SNDX
$1.69B
$15.1M 2.36%
723,061
+40,000
+6% +$833K
MRK icon
9
Merck
MRK
$322B
$13.9M 2.17%
120,600
– –
AMD icon
10
CALL
Advanced Micro Devices
AMD
$776B
$13.7M 2.13%
+120,000
New +$12.5M
TSEM icon
11
PUT
Tower Semiconductor
TSEM
$24.8B
$12.5M 1.95%
+332,100
New +$13.7M
MSFT icon
12
Microsoft
MSFT
$3.45T
$11.7M 1.82%
34,312
-20,311
-37% -$6.37M
PRAX icon
13
Praxis Precision Medicines
PRAX
$8.58B
$10.1M 1.57%
+584,289
New +$8.95M
NVO
14
Novo Nordisk
NVO
$208B
$9.15M 1.43%
113,080
-30,000
-21% -$2.45M
SRPT icon
15
CALL
Sarepta Therapeutics
SRPT
$1.57B
$8.97M 1.4%
+78,300
New +$10.1M
PNT
16
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$8.63M 1.35%
952,642
– –
RARE icon
17
Ultragenyx Pharmaceutical
RARE
$2.45B
$8.47M 1.32%
183,696
– –
NVMI
18
Nova
NVMI
$12.4B
$8.21M 1.28%
+70,000
New +$7.16M
SWTX
19
DELISTED
SpringWorks Therapeutics
SWTX
$8.2M 1.28%
312,625
-5,000
-2% -$131K
SHLT
20
DELISTED
SHL Telemedicine Ltd American Depositary Shares
SHLT
$7.96M 1.24%
+714,573
New +$7.92M
TEVA icon
21
Teva Pharmaceuticals
TEVA
$40.8B
$7.91M 1.23%
1,050,000
-989,500
-49% -$8.02M
GNRC icon
22
CALL
Generac Holdings
GNRC
$11.6B
$7.83M 1.22%
+52,500
New +$5.98M
ALNY icon
23
Alnylam Pharmaceuticals
ALNY
$27.5B
$7.6M 1.19%
+40,000
New +$7.93M
IRON icon
24
Disc Medicine
IRON
$2.94B
$7.57M 1.18%
170,578
-49,435
-22% -$1.75M
ABBV icon
25
AbbVie
ABBV
$443B
$7.54M 1.18%
56,000
-7,000
-11% -$1.03M
1
2 3 4 5

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q2 2023 Portfolio in Review

As of Q2 2023, Sphera Funds Management held 108 positions worth $640M, up 7% from $598M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Sphera Funds Management deployed $22.9M of net new capital in Q2 2023, opening 27 new positions and adding to 17 existing holdings. Its largest new stake was Praxis Precision Medicines: 584,289 shares worth $10.1M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $8.02M trimmed.

  • Sphera Funds Management's largest Q2 2023 buy was Praxis Precision Medicines: 584,289 shares worth $10.1M.
  • Sphera Funds Management added most to Amazon in Q2 2023, an estimated $4.41M increase.
  • Sphera Funds Management's biggest Q2 2023 reduction was Teva Pharmaceuticals, cutting an estimated $8.02M.
  • Sphera Funds Management fully exited Nutrien in Q2 2023, selling an estimated $10.7M.
  • Sphera Funds Management's ten largest holdings make up 40% of its $640M portfolio in Q2 2023.
  • Sphera Funds Management opened 27 new positions and closed 21 in Q2 2023.
  • Sphera Funds Management's portfolio value rose 7% quarter-over-quarter to $640M.

Based on Sphera Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.